Moleculin Biotech Inc Stock Ownership - Who owns Moleculin Biotech?

Insider buying vs selling

Have Moleculin Biotech Inc insiders been buying or selling?
Walter V. KlempCEO and President2023-07-113,216$0.59
Walter V. KlempCEO and President2023-07-023,584$0.58
Walter V. KlempCEO and President2023-06-2013,697$0.57
Jonathan P. FosterChief Financial Officer2023-06-209,676$0.57
Donald H. PickerChief Science Officer2023-06-204,267$0.57
Jonathan P. FosterChief Financial Officer2023-06-163,044$0.57
Walter V. KlempCEO and President2023-06-166,088$0.57
Walter V. KlempCEO and President2022-11-2545,000$1.28
Walter V. KlempCEO and President2022-11-2122,500$1.15
Walter V. KlempCEO and President2022-11-1724,742$1.02

1 of 2

MBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MBRX insiders and whales buy or sell their stock.

MBRX Shareholders

What type of owners hold Moleculin Biotech Inc stock?
Waldemar Priebe12.23%3,645,573$1.56MInsider
Walter V. Klemp5.26%1,567,476$669.31kInsider
Vanguard Group Inc3.62%1,080,122$461.21kInstitution
Donald H. Picker2.15%642,006$274.14kInsider
Sio Capital Management LLC1.02%303,389$129.55kInstitution
Geode Capital Management LLC0.83%246,451$105.23kInstitution
Blackrock Inc0.66%196,196$83.78kInstitution
Renaissance Technologies LLC0.43%127,400$54.40kInstitution
Squarepoint Ops LLC0.26%77,238$32.98kInstitution
State Street Corp0.24%71,397$30.49kInstitution

1 of 3

MBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MBRX7.67%19.82%Net BuyingNet Selling
SYBX22.46%77.54%Net Selling
EIGR43.29%56.71%Net Buying

Moleculin Biotech Stock Ownership FAQ

Who owns Moleculin Biotech?

Moleculin Biotech (NASDAQ: MBRX) is owned by 7.67% institutional shareholders, 19.82% Moleculin Biotech insiders, and 72.51% retail investors. Waldemar Priebe is the largest individual Moleculin Biotech shareholder, owning 3.65M shares representing 12.23% of the company. Waldemar Priebe's Moleculin Biotech shares are currently valued at $1.59M.

If you're new to stock investing, here's how to buy Moleculin Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.